English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Department of Radiation Oncology at Cedars-Sinai Cancer has earned accreditation from the American Society for Radiation Oncology (ASTRO) Accreditation Program for Excellence.
Tag: Howard Sandler
Cedars-Sinai Cancer Experts Available to Discuss ASCO 2023 News
Cedars-Sinai Cancer physician-scientists with expertise in liver, skin, lung, breast, colorectal, pancreatic, brain, prostate and endometrial cancers will be attending the American Society of Clinical Oncology annual meeting June 2-6 in Chicago and are available for in-person or virtual interviews to discuss the latest news and research.
Cedars-Sinai Radiation Oncologists Featured at ASTRO 2022
Physician scientists from the Department of Radiation Oncology at Cedars-Sinai Cancer will present research and discuss advances in clinical care at the American Society for Radiation Oncology (ASTRO) annual meeting Oct. 23-26 in San Antonio.
Radiation Oncology Expert Joins Cedars-Sinai Cancer
Marc Botnick, MD, a board-certified radiation oncologist with more than 20 years of experience managing all cancer types, has been named regional medical director for Radiation Oncology at Cedars-Sinai Cancer. His primary clinical practice site will be at Cedars-Sinai Tarzana Radiation Oncology, but he will work closely with physicians throughout the enterprise.
Cedars-Sinai’s Howard Sandler, MD, Elected President of ASTRO
Howard Sandler, MD, chair of the Department of Radiation Oncology at Cedars-Sinai Cancer, has been named president-elect of the American Society for Radiation Oncology (ASTRO). Sandler will begin his term as president-elect in October, followed by single-year terms as president, chair and then immediate past chair of the ASTRO Board.
Cedars-Sinai July Research Highlights
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Cedars-Sinai Cancer Experts Present Breakthroughs at 2022 ASCO Annual Meeting
Experts from Cedars-Sinai Cancer, ranked among the top 10 in the nation for cancer care, will present novel research and clinical advances throughout the 2022 annual meeting of the American Society of Clinical Oncology (ASCO), taking place in person and virtually June 3-7 in Chicago.